News

Merck’s (NYSE:MRK) Q2 Earnings Results: Revenue In Line With Expectations
Global pharmaceutical company Merck (NYSE:MRK) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 1.9% ...
Fierce Pharma18h
Merck joins Big Pharma cost-cutting crowd, revealing plan to save $3B annually by 2027
Merck has launched a sweeping cost-cutting effort designed to save $3 billion annually by the end of 2027, the company said ...
Fierce Biotech11h
Merck axes midstage asset from $1.9B Pandion buyout due to lack of clinical benefit
As Merck & Co. rolls out a widespread cost-cutting initiative, the pharma is dropping an autoimmune asset acquired a few years ago in a nearly $2 billion biotech takeover.
Merck to Lay Off Workers and Narrows Guidance as Earnings Fall
Merck said it is embarking on a multi-year cost-savings plan, which includes cuts to its workforce and real-estate footprint, ...
NJBIZ10h
Merck moves to cut $3B, jobs in latest restructuring
Along with its financial results for the second quarter of 2025, Merck revealed a restructuring plan to save $3 billion by ...
Daily Voice on MSN10h
Rahway-Based Merck Stock Drops, Layoffs Begin In $3B Restructuring Plan
Merck, a pharmaceutical company headquartered in Rahway, announced it will be undergoing layoffs after a disappointing second ...
Merck Stock Is Almost A Classical Benjamin Graham Investment
Merck is a strong and profitable pick meeting Benjamin Graham's criteria. Read more on why investors need to stay aware of ...
Merck to cut jobs and costs as demand for Gardasil in China remains weak
Merck & Co on Tuesday announced job and cost cuts that it said will save $3 billion a year, after it posted lower ...